✅ Prescription Required
Rx Incurin 1 mg 30 Count Tablet
Incurin® (estriol) is a veterinary prescription hormonal therapy used in female dogs for the treatment of urinary incontinence that results from low estrogen levels associated with spaying. By supplementing estriol, Incurin® helps restore urethral tone, reducing involuntary urine leakage and improving quality of life for affected dogs.
Key Details:
-
Strength & Count: 1 mg tablets; 30 ct.
-
Class: Estrogen hormone therapy.
-
Indication (Dogs): Management of urinary incontinence due to estrogen deficiency in spayed female dogs.
-
Canine/Feline/Equine Safety: Not approved for cats, horses, or male dogs. For female dogs only.
-
Use Only Under Vet Supervision: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. Avoid handling if pregnant or breastfeeding. Wash hands thoroughly after administering.
-
Contraindications/Cautions: Do not use in intact female dogs, or in dogs with known estrogen-sensitive tumors. Safety not established in breeding, pregnant, or lactating dogs. Use the lowest effective dose and adjust under veterinary guidance.
-
Storage: Store at 68–77°F (20–25°C). Protect from moisture and light.
Regulatory: Prescription required; federal law restricts this drug to use by or on the order of a licensed veterinarian.
Keep away from children and other household pets.
This item is not returnable or refundable.
Sold in Qty. of 1 (30 ct.).
| Product type: |
Animal Health & Wellness > Medicine |
| Brand: |
Incurin |
| Status: |
Available |
| Animal type: |
Dog |
| Ingredients: |
1 mg of estriol per tablet. |
| Cautions & Warnings: |
Human Warnings: Not for human use. Keep out of the reach of children. Women who are of child-bearing age or those who are breastfeeding should use caution when administering INCURIN Tablets. Wash your hands with soap and water after administration to avoid exposure to the drug. Consult a physician in case of accidental ingestion by humans. Animal Warnings: Some estrogens have been associated with bone marrow changes and an increased risk of mammary tumors. However, target animal safety study results and foreign post-market pharmacovigilance data for INCURIN Tablets have shown that estriol-treated dogs are at low risk for developing these conditions. |
| Dosage instructions: |
The dose of INCURIN Tablets is not dependent upon body weight. All dogs should receive an initial dose of 2 mg INCURIN Tablets (2 tablets) orally once per day for a minimum of 14 days. After urinary incontinence is controlled, the lowest effective daily dose of INCURIN Tablets should be determined by decreasing the dose in a step-wise manner from 2 mg once daily (2 tablets) to 1 mg once daily (1 tablet), then 0.5?mg once daily (1/2 tablet) depending upon the response of the individual dog. There should be a minimum of 7 days between each dose adjustment. After the lowest daily dose that controls urinary incontinence is identified, the dose may be decreased further by administering once every two days. Dogs should not receive more than 2 mg INCURIN Tablets per day (2?tablets). If the dog does not respond to 2 mg of INCURIN Tablets per day, the diagnosis should be re-assessed. |
| Weight: |
0.03 |
| Prescription required: |
YES |
| GTIN: |
8713184108456 |
